Is weed a responsible investment?

Do the medical applications of cannabis make it an ESG-positive investment? Or do the recreational applications make it a vice, and therefore ESG-negative?

Andrew Willis 10 July, 2019 | 2:42PM

Cannabis extract medicine bottles

Note: This article is part of Morningstar Canada's Cannabis Week Special Report

It was a fateful day in November 2016 when Canopy Growth Corporation was crowned the first “cannabis unicorn”, reaching a billion-dollar valuation after soaring nearly 400% in the preceding year. What followed was a deluge of mainstream media coverage, and some soul-searching among average investors weighing whether they were ready to jump on the profit bandwagon or sit on the sidelines.

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

To view this article, become a Morningstar Basic member.

Register For Free

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar Rating
Cardiol Therapeutics Inc3.15 CAD11.31
InMed Pharmaceuticals Inc0.21 EUR0.00
Tetra Bio Pharma Inc0.23 CAD0.00

About Author

Andrew Willis

Andrew Willis  Andrew Willis is a content editor for Morningstar.ca.

© Copyright 2020 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Member User Agreement        Cookies